Estimates

Source: S&P Capital IQ consensus via Xpressfeed · Generated 2026-07-19.

Street snapshot

All six covering analysts rate FinVolution a buy, giving a consensus recommendation score of 1. Target prices span CNY 39.32 to 61.58, with a mean of about 49.26 across six estimates.

Currency: CNY · Scale: money in millions, absolute (per share) · Analyst counts shown explicitly; recommendation respondents: 6.

Street view Reading Analysts
Recommendation mix Buy 6, Outperform 0, Hold 0, Underperform 0, Sell 0 6
Consensus score 1.00 6
Target price mean 49.26; high 61.58; low 39.32 6

Forward table

Forward quarterly coverage is thin, limited mostly to dividend-per-share estimates.

Currency: CNY · Scale: money in millions, absolute (per share) · Analyst count is the estimate count for each period and metric.

Period Metric Mean YoY Analysts Low / high
FY0E Revenue 12,686 -6.5% 5 12,022 / 13,248
FY0E EBITDA 2,339 -24.6% 1 2,339 / 2,339
FY0E EBIT 2,261 -22.5% — / —
FY0E Net income (GAAP) 1,967 -22.6% 5 1,748 / 2,095
FY0E Net income (normalized) 2,092 -22.3% — / —
FY0E EPS (GAAP) 8.18 -14.7% 4 7.84 / 8.46
FY0E EPS (normalized) 8.31 -18.1% 4 7.84 / 9.07
FY0E Free cash flow 533.0 -68.0% — / —
FY0E Dividend per share 2.08 -13.9% — / —
FY0E Capital expenditure -26.00 67.7% — / —
FY0E ROE 11.9% -25.2% — / —
FY0E Cash from operations 3,159 55.8% — / —
FY+1E Revenue 13,555 6.8% 5 12,927 / 14,058
FY+1E EBITDA 2,461 5.2% 1 2,461 / 2,461
FY+1E EBIT 2,576 14.0% — / —
FY+1E Net income (GAAP) 2,309 17.4% 5 2,176 / 2,507
FY+1E Net income (normalized) 2,457 17.4% — / —
FY+1E EPS (GAAP) 9.69 18.6% 4 8.27 / 10.44
FY+1E EPS (normalized) 9.75 17.3% 4 8.27 / 11.07
FY+1E Free cash flow 1,834 244.1% — / —
FY+1E Dividend per share 2.43 16.9% — / —
FY+1E Capital expenditure -27.50 5.8% — / —
FY+1E ROE 12.5% 4.8% — / —
FY+1E Cash from operations 2,232 -29.3% — / —
FY+2E Revenue 14,779 9.0% 3 14,165 / 15,248
FY+2E EBIT 2,990 16.1% — / —
FY+2E Net income (GAAP) 2,654 14.9% 3 2,481 / 2,771
FY+2E Net income (normalized) 2,829 15.1% — / —
FY+2E EPS (GAAP) 11.33 16.9% 3 11.02 / 11.52
FY+2E EPS (normalized) 11.18 14.7% 3 10.00 / 12.08
FY+2E Free cash flow 2,370 29.2% — / —
FY+2E Dividend per share 2.66 9.1% — / —
FY+2E Capital expenditure -20.00 -27.3% — / —
FY+2E ROE 12.6% 0.9% — / —
FY+2E Cash from operations 2,390 7.1% — / —
Q3 FY2024 Dividend per share 0.00 — / —
Q4 FY2024 Dividend per share 2.05 — / —
Q2 FY2025 Dividend per share 0.00 — / —
Q3 FY2025 Dividend per share 0.00 — / —

Estimate momentum

FY2028 estimates were nudged lower on a similar path, so the revisions are broad rather than a single-period move.

Currency: CNY · Scale: money in millions, absolute (per share) · Point-in-time consensus; analyst count is shown where supplied.

Period Metric Lookback Then Now Direction / magnitude Analysts
2028 Revenue 30d 14,779 14,779 flat 0.0%
2028 Revenue 90d 15,175 14,779 down 2.6%
2028 EPS (normalized) 30d 11.18 11.18 flat 0.0%
2028 EPS (normalized) 90d 11.37 11.18 down 1.7%
2027 Revenue 30d 13,829 13,555 down 2.0%
2027 Revenue 90d 14,051 13,555 down 3.5%
2027 Revenue 180d 14,384 13,555 down 5.8%
2027 EPS (normalized) 30d 10.10 9.75 down 3.5%
2027 EPS (normalized) 90d 10.00 9.75 down 2.6%
2027 EPS (normalized) 180d 10.59 9.75 down 7.9%

Beat / miss record

Current sequences by metric: Revenue: 2 consecutive misses; EPS (normalized): 3 consecutive beats.

Currency: CNY · Scale: money in millions, absolute (per share) · Consensus is captured before each actual first became effective; analyst count shown per observation.

Quarter Metric Consensus as of Actual Surprise Outcome Analysts
Q4 FY2025 Revenue 3,078 3,024 -1.8% Miss
Q4 FY2025 EPS (normalized) 1.61 1.77 9.9% Beat
Q3 FY2022 Revenue 2,800 2,525 -9.8% Miss
Q2 FY2022 Revenue 2,600 2,666 2.5% Beat
Q4 FY2021 EPS (normalized) 2.00 2.36 18.0% Beat
Q1 FY2020 Revenue 650.9 2,106 223.6% Beat
Q1 FY2020 EPS (normalized) 0.21 1.36 540.0% Beat
Q4 FY2019 Revenue 1,114 1,233 10.7% Beat
Q4 FY2019 EPS (normalized) 1.32 1.32 -0.1% Miss

Where the street disagrees

Disagreement is concentrated in the out-year normalized EPS, where FY2027 spans CNY 8.27 to 11.07 (standard deviation ~1.02). Estimate counts there are small — four or fewer — and single-broker items such as EBITDA weaken the signal further.

Currency: CNY · Scale: money in millions, absolute (per share) · Dispersion is high-low divided by absolute mean; analyst count shown per item.

Period Metric Mean Low High Spread / mean Analysts
2027 EPS (normalized) 9.75 8.27 11.07 28.8% 4
2027 EPS (GAAP) 9.69 8.27 10.44 22.4% 4
2028 EPS (normalized) 11.18 10.00 12.08 18.6% 3
2026 Net income (GAAP) 1,967 1,748 2,095 17.6% 5
2026 EPS (normalized) 8.31 7.84 9.07 14.8% 4